The Chemistry of Binders

By ​ Pete Wurst

​There is a principle in toxicology and integrative medicine that is as elegantly simple as it is clinically consequential.

Once a toxin has been mobilised — pulled from its storage location in fatty tissue, bone, or cellular compartments — and processed by the liver for elimination through bile — it enters the intestinal tract. And there, unless something intervenes, a significant proportion of it does not leave.

It is Reabsorbed.

​Bile recirculates. The enterohepatic circulation — the physiological loop by which bile acids and their associated cargo are reabsorbed from the small intestine and returned to the liver for reprocessing — is one of the most efficient recycling systems in the human body.

It is enormously valuable for conserving bile acids, fat-soluble vitamins, and other molecules the body wants to retain.

But it does not discriminate well. The lipophilic toxins that the liver has conjugated and packaged into bile for elimination — heavy metals, mycotoxins, persistent organic pollutants, hormone metabolites, bacterial endotoxins, pharmaceutical metabolites — are reabsorbed alongside the bile acids the body legitimately needs to recycle.

They re-enter the portal circulation. Return to the liver for reprocessing. Generate oxidative stress and burden Phase 1 and Phase 2 enzymes that are already working at capacity. And recirculate through the body again.

A binder interrupts this cycle.

A binder is a substance — a molecule, a mineral, a fibre, a clay, a resin — that binds specific toxins, pathogens, or inflammatory compounds in the gastrointestinal tract and holds them sufficiently firmly that they pass through the intestine and are eliminated in stool rather than being reabsorbed.

Not every binder binds every toxin. The chemistry of binding is specific — different binders have different affinities for different types of molecules based on charge, size, polarity, and molecular structure. Using the right binder for the right toxin is a matter of matching chemistry to clinical context.

And using binders at the wrong time — or without adequate drainage pathway support — can produce its own consequences: binding nutrients alongside toxins, drawing toxins that have not been properly processed into the wrong compartments, or creating constipation that backs up the very pathway the binder was meant to support.

This guide covers the full science of binders — what they are, how they work, which ones bind which toxins, how to use them correctly, and how they fit into the broader drainage and detoxification framework.

↓ Keep reading. Binders are one of the most powerful and most misunderstood tools in integrative medicine.

​Support Pete's Healing Work
If his research helped you understand your body in a deeper way — and you want more info like this
https://holisticdoggo.carrd.co

𝐖𝐇𝐀𝐓 𝐁𝐈𝐍𝐃𝐄𝐑𝐒 𝐀𝐂𝐓𝐔𝐀𝐋𝐋𝐘 𝐀𝐑𝐄 — 𝐓𝐇𝐄 𝐂𝐇𝐄𝐌𝐈𝐒𝐓𝐑𝐘

A binder is any substance that reduces the absorption of specific compounds from the gastrointestinal tract through binding — adsorption or absorption — holding the target compound in the intestinal lumen until it is eliminated in stool.

Two Types of Binding:
→ Adsorption — the target molecule adheres to the surface of the binder particle through electrostatic interactions, van der Waals forces, hydrogen bonding, or hydrophobic interactions; the target molecule is held on the surface of the binder without chemically reacting with it; most mineral and clay binders work primarily through adsorption.

→ Absorption — the target molecule is incorporated into the internal structure of the binder matrix; some fibres and resins work through absorption into their gel-like or porous structures.

The Key Properties of an Effective Binder:
→ Affinity — how strongly the binder attracts and holds the target molecule; a binder must have greater affinity for the target than the intestinal epithelium or bile acids have; otherwise the target will be competitively displaced and reabsorbed.

→ Selectivity — how specifically the binder attracts the target relative to other molecules (particularly nutrients and beneficial compounds); an ideal binder would bind only the target toxin and nothing else; in practice no binder is perfectly selective.

→ Binding Capacity — how much of the target molecule can be bound per gram of binder; relevant for dosing and for understanding how much binder is needed relative to toxin load.

→ Stability — the bound complex must remain stable through the intestinal transit; if the binder releases the target in response to pH changes, enzymatic activity, or competitive displacement, the toxin re-enters the lumen and may be reabsorbed.

→ Non-absorption — the binder itself must not be absorbed; it must pass through the intestine intact to carry its bound load out in stool; all effective binders are non-absorbable.

→ Safety — the binder must not cause harm through its own chemistry or through binding essential nutrients at levels that produce deficiency.

The Enterohepatic Circulation — What Binders Interrupt:
As described — the enterohepatic circulation is the primary mechanism through which toxins that have been excreted in bile are recycled back into the body:

→ The liver processes toxins through Phase 1 and Phase 2 detoxification — producing conjugated, bile-ready forms.

→ These conjugates are excreted in bile through bile canaliculi into the bile ducts and then into the small intestine.

→ In the terminal ileum — bile acids are reabsorbed through the ASBT (apical sodium-dependent bile transporter) along with their associated lipophilic cargo.

→ Reabsorbed bile returns through the portal circulation to the liver — with whatever lipophilic toxins were attached.

→ This cycle can be completed 6–10 times daily — each cycle potentially returning toxins to the circulation.

Binders interrupt this cycle at the intestinal lumen — by binding conjugated toxins before they can be reabsorbed — effectively capturing them for elimination rather than allowing their return through the enterohepatic loop.

𝐓𝐇𝐄 𝐌𝐀𝐉𝐎𝐑 𝐁𝐈𝐍𝐃𝐄𝐑𝐒 — 𝐌𝐄𝐂𝐇𝐀𝐍𝐈𝐒𝐌𝐒 𝐀𝐍𝐃 𝐂𝐋𝐈𝐍𝐈𝐂𝐀𝐋 𝐀𝐏𝐏𝐋𝐈𝐂𝐀𝐓𝐈𝐎𝐍𝐒

Activated charcoal — the broad-spectrum emergency binder

What it is:
Activated charcoal is produced by heating carbon-containing material (wood, coconut shells, bamboo, coal) to high temperatures and then treating with oxidising gas — producing an extraordinarily porous structure with an enormous surface area — typically 500–1,500 square metres per gram.

This porosity makes activated charcoal one of the most effective physical adsorbing agents known.

Mechanism:
→ Adsorption — the enormous surface area provides an extraordinarily large number of binding sites for organic molecules; toxins and drugs adsorb to charcoal through hydrophobic interactions and van der Waals forces.

→ Does not bind through chemical reaction — it captures molecules physically in its porous matrix; the bound complex is stable as long as the charcoal is not overwhelmed by competing molecules

What it Binds:
→ Most organic compounds — activated charcoal has broad-spectrum binding capacity for organic molecules; drugs, medication overdoses (the primary emergency medicine application), alcohol, mycotoxins (particularly aflatoxin and ochratoxin A), bacterial toxins, and many synthetic chemicals.

→ Clinical emergency medicine gold standard — for many drug overdoses (particularly acetaminophen before peak absorption, tricyclic antidepressants, many other pharmaceuticals); administered as a single large dose or repeat doses in specific overdose scenarios.

→ Mycotoxins — activated charcoal binds aflatoxin with high efficiency; used in food processing and in animal feed to reduce aflatoxin contamination; in human integrative medicine — relevant for reducing gut absorption of dietary mycotoxins from contaminated food.

→ Bacterial lipopolysaccharide (LPS) — moderate binding capacity for LPS (bacterial endotoxin); relevant for reducing the systemic inflammatory burden from gut dysbiosis and increased intestinal permeability.

→ Bile acids — binds bile acids; relevant consideration because bile acid binding can interfere with the enterohepatic recirculation of genuinely needed bile acids and fat-soluble vitamins.

What it does NOT bind well:
→ Heavy metals — activated charcoal has poor affinity for ionic heavy metals (mercury, lead, arsenic, cadmium); not the appropriate binder for heavy metal detoxification.

→ Alcohols — poor binding of small alcohol molecules like ethanol.

→ Caustic substances — does not bind strong acids or alkalis.

→ Lithium, potassium, iron — specific inorganic compounds not well bound.

Practical Considerations:
→ Take 2 hours away from all medications, supplements, and food — the broad-spectrum binding of activated charcoal means it will bind medications and nutrients alongside toxins; strict timing around other inputs is essential.

→ Short-Term Use Primarily — the broad binding of activated charcoal means that extended regular use risks binding essential nutrients including fat-soluble vitamins and some minerals; most appropriate for acute or short-course applications.

→ Constipation risk — activated charcoal can produce constipation through its binding of gut contents; ensure adequate hydration and bowel motility support when using.

→ Black Stool — expected; reassure patients this is normal.

→ Dosing: 500mg–2g per dose, 2–3 times daily; away from other supplements and medications; acute applications may use higher doses.

Cholestyramine (CSM) — the mycotoxin and biotoxin specialist.

What it is:
Cholestyramine is a Synthetic Bile Acid Sequestrant — a quaternary ammonium ion exchange resin — originally developed and still used as a pharmaceutical cholesterol-lowering agent (by binding bile acids in the gut, reducing their reabsorption, and forcing the liver to convert more cholesterol to new bile acids, thus lowering plasma cholesterol).

In Integrative Medicine — cholestyramine is used primarily as a binder for mycotoxins and biotoxins in the context of chronic inflammatory response syndrome (CIRS) — the condition described by Dr. Ritchie Shoemaker associated with mould illness and biotoxin exposure.

Mechanism:
→ Ion Exchange — CSM is positively charged; it binds negatively charged molecules through electrostatic attraction; bile acids are negatively charged; mycotoxins and biotoxins carry varying charges but many bind to CSM with high affinity.

→ High Binding Capacity — CSM can bind very large quantities of bile acids and their associated lipophilic cargo per gram.

What it Binds:
→ Bile Acids — the primary pharmaceutical target; binds bile acids with very high affinity preventing their reabsorption.

→ Mycotoxins — particularly trichothecenes (from Stachybotrys chartarum — black mould), ochratoxin A, and other polar mycotoxins; CSM binding of mycotoxins is the basis of Shoemaker's CIRS treatment protocol.

→ Biotoxins — various biological toxins from dinoflagellates (ciguatoxin, brevetoxin), cyanobacteria, and other sources.

→ Lipophilic Compounds Broadly — the bile acid sequestrant mechanism captures fat-soluble compounds associated with bile acids in the enterohepatic circulation.

What it Does NOT Bind Well:
→ Non-polar mycotoxins — gliotoxin and some other Aspergillus-derived mycotoxins are not well bound by CSM; these may be better addressed by activated charcoal or Welchol.

→ Heavy metals — poor heavy metal binding.

Practical Considerations:
→ Prescription Required — CSM is a pharmaceutical; available by prescription; most commonly used in integrative medicine contexts specifically for CIRS/mould illness under medical supervision

→ Major Nutrient Binding Concern — CSM binds fat-soluble vitamins (A, D, E, K) with significant efficiency; long-term CSM use without supplementation of fat-soluble vitamins produces clinically significant deficiencies; vitamin supplementation should always accompany CSM use and should be timed separately.

→ Constipation — a consistent side effect; requires active colon drainage support (magnesium, fibre, hydration).

→ Medication Interactions — significant; binds many medications; all medications and most supplements should be taken 1–2 hours before or 4–6 hours after CSM.

→ Colesevelam (Welchol) — a newer bile acid sequestrant with a different chemical structure; less prone to some of CSM's nutrient binding interactions; better tolerated; used in integrative medicine as an alternative to CSM for biotoxin and mycotoxin binding; available by prescription.

→ Dosing: CSM typically 4g (one packet) 2–4 times daily — as per Shoemaker protocol; always away from medications and with fat-soluble vitamin supplementation.

Bentonite Clay — the heavy metal and bacterial toxin binder.

What it is:
Bentonite is a type of smectite clay — an aluminosilicate clay mineral — formed from volcanic ash; named after Fort Benton, Wyoming where large deposits were found. Food-grade sodium bentonite and calcium bentonite are the forms used therapeutically.

Mechanism:
→ Ion Exchange — bentonite clay carries a permanent negative charge on its surface layers; heavy metal cations (positively charged) are attracted and bound through electrostatic exchange; the clay particle swells in water and the interlayer spaces expand, increasing accessible surface area.

→ Physical Adsorption — organic compounds adsorb to the clay surface through van der Waals forces and hydrophobic interactions.

→ Absorption Into Interlayer Spaces — the expanding interlayer spaces of swollen bentonite physically trap molecules between clay layers.

What it Binds:
→ Heavy Metals — particularly lead, cadmium, mercury, and arsenic; multiple studies documenting bentonite clay binding of heavy metal cations; the negative surface charge and cation exchange capacity of bentonite makes it well-suited for cationic heavy metal binding.

→ Bacterial Toxins — particularly aflatoxin (bentonite is one of the most studied aflatoxin binders in both animal and human research; used in food processing and in clinical protocols for aflatoxin exposure in developing countries); LPS from gram-negative bacteria; Clostridium difficile toxins.

→ Mycotoxins — aflatoxin most specifically; variable binding of other mycotoxins depending on their charge and polarity.

→ Pesticides and Herbicides — some organophosphate and organochlorine compounds adsorb to bentonite.

→ Viruses and Bacteria — physical trapping of pathogenic organisms within the clay matrix

What it Does NOT Bind Well:
→ Non-polar organic toxins — the clay's primarily electrostatic mechanism is less effective for non-polar compounds.

→ Some Mycotoxins — ochratoxin and trichothecenes are less well bound than aflatoxin.

Practical Considerations:
→ Aluminium Content Concern — bentonite clay is an aluminosilicate; the aluminium it contains is in a crystalline, silicate-bound form that is largely non-absorbable; however in acidic gut conditions some aluminium may be released; people with kidney disease or aluminium sensitivity should use with caution; quality-sourced, tested clay products with documented low free aluminium are preferred.

→ Hydration Critical — bentonite clay absorbs water; adequate hydration is essential when using bentonite to prevent it from bulking and causing intestinal obstruction; drink an extra 500ml–1L of water per day during use.

→ Constipation Risk — as with all binders; ensure colon drainage is open.

→ Take Away From Medications and Nutrients — electrostatic binding may capture some cationic minerals and some drug molecules; 2-hour separation from all other inputs.

→ Dosing: 1–2 teaspoons of food-grade clay powder in water, 1–2 times daily; always with adequate water.

Zeolite — the structured mineral binder for heavy metals.

What it is:
Zeolites are microporous aluminosilicate minerals with a characteristic three-dimensional crystal lattice structure containing negatively charged cages and channels of precise dimensions.

Mechanism:
→ Size-Selective Ion Exchange — the zeolite crystal structure contains channels of specific dimensions that selectively admit molecules and ions of matching size; this size selectivity gives zeolite a more targeted binding profile than the less discriminating bentonite clay.

→ High Cation Exchange Capacity — the negative lattice charge strongly attracts positively charged heavy metal cations; the binding selectivity of clinoptilolite follows a characteristic series: Pb²⁺ > NH₄⁺ > Ba²⁺ > Cu²⁺ > Zn²⁺ > Cd²⁺ > Cs⁺ > Co²⁺ > Cr³⁺ > Mn²⁺ > Ni²⁺

What it Binds:
→ Heavy metals — lead, cadmium, mercury, arsenic, and caesium with high affinity; has shown heavy metal binding capacity in laboratory, animal, and limited human studies; multiple human and animal studies documenting clinoptilolite binding of heavy metals in the GI tract.

→ Ammonium (NH₄⁺) — clinoptilolite has particularly high affinity for ammonium ions; relevant for reducing gut-derived ammonia production — a significant issue in gut dysbiosis, SIBO, and liver disease; reducing gut ammonia absorption reduces the neurological and inflammatory burden of hyperammoniaemia.

→ Radioactive caesium (¹³⁷Cs) — zeolite was used after the Chernobyl nuclear accident to reduce radioactive caesium absorption in contaminated populations; one of the most dramatic demonstrations of zeolite binding efficacy.

→ Some Mycotoxins — variable; ochratoxin A shows some binding affinity for clinoptilolite.

→ Bacterial Toxins — some binding of LPS and other bacterial products.

→ Nitrosamines — carcinogenic compounds from processed meat and tobacco smoke; zeolite shows binding affinity.

What it Does NOT Bind:
→ Non-Charged Organic Compounds — the ion exchange mechanism primarily targets charged species; non-polar organic toxins have lower affinity.

→ Bile Acids — relatively low bile acid binding compared to CSM; an advantage in terms of reduced interference with bile recirculation.

Contamination Risk
Very Important For:
• zeolite
• bentonite
• chlorella

Some Products Have Been Contaminated With:
• lead
• arsenic
• aluminum
• microbes

Third-party testing matters enormously.
Chlorella — the algae-based heavy metal and mycotoxin binder

What It Is:
Chlorella is a single-celled green freshwater algae — extraordinarily rich in chlorophyll (the highest chlorophyll concentration of any known food), protein (50–60% by dry weight), vitamins, minerals, and the unique Chlorella Growth Factor (CGF) — a nucleotide-peptide complex supporting cellular regeneration.

Mechanism:
→ Cell Wall Binding — the fibrous cell wall of Chlorella pyrenoidosa (the species with the thickest, most bioactive cell wall — distinct from C. vulgaris) contains polysaccharides and glycoproteins with specific affinity for heavy metal cations; the cell wall acts as an ion exchange matrix binding mercury, lead, cadmium, and arsenic.

→ Chlorophyll binding — chlorophyll — a porphyrin ring structure containing a central magnesium atom.
 
→Has documented affinity for heavy metals; heavy metal cations can displace the central magnesium atom and be chelated by the porphyrin ring structure.

→ Sporopollenin-Like Compounds — the outer cell wall of C. pyrenoidosa contains sporopollenin-like compounds (similar to the extraordinarily chemically resistant outer layer of pollen grains) that are highly resistant to enzymatic digestion and may contribute to binding capacity through physical trapping.

→ Glutathione Content — chlorella provides cysteine and glutathione precursors; indirectly supports cellular heavy metal chelation rather than only gut-lumen binding.

What it Binds:
→ Heavy Metals — particularly mercury, lead, and cadmium; multiple animal studies and human clinical studies documenting reduced heavy metal absorption and increased heavy metal excretion with chlorella supplementation.

→ A landmark Japanese study demonstrated that chlorella supplementation significantly reduced prenatal mercury transfer in pregnant women with amalgam fillings — a specific and clinically important finding.

→ Persistent organic pollutants (POPs) — dioxins, PCBs; studies in nursing mothers showing reduced dioxin levels in breast milk with chlorella supplementation; significant clinical evidence for dioxin binding.

→ Mycotoxins — some binding affinity for aflatoxin and other mycotoxins.

→ Cadmium — from cigarette smoke and contaminated food; specific binding studies in rodent models.

What it Does NOT Bind:
→ Not the primary binder for non-organic toxins or for water-soluble compounds that do not interact with the cell wall chemistry.

Practical Considerations:
→ Cell Wall Processing Matters Enormously — intact, unbroken chlorella cell walls are not digestible by human enzymes; the nutrients inside are inaccessible unless the cell wall is broken through mechanical processing; but for binding purposes, an intact cell wall may actually be preferable — the cell wall is the primary binding matrix; a product with "broken cell wall" releases nutrients more effectively but may have reduced binding capacity; some practitioners use intact cell wall chlorella specifically for binding and broken cell wall for nutrition.

→ Contamination Risk — chlorella can accumulate heavy metals from its growing water; only use chlorella from suppliers with rigorous contamination testing; third-party tested for heavy metals is essential.

→ Chlorella Growth Factor — CGF supports cellular repair and regeneration alongside the binding function; makes chlorella one of the most nutritionally comprehensive binders.

→ Dosing: 2–4g daily for general heavy metal support; up to 6–10g daily in intensive detoxification protocols; start low (1g) and build gradually — chlorella mobilisation of stored toxins can produce detox reactions in heavily burdened individuals if the dose increases too rapidly; always take away from other supplements and medications.

Modified Citrus Pectin (MCP) — the Heavy Metal and Cancer-Relevant Binder

What It Is:
Modified Citrus Pectin is a Form of Pectin — the soluble fibre found in citrus fruit peel — that has been pH and temperature modified to break the long pectin chains into shorter galactose-rich fragments (approximately 10–15 kilodaltons). This modification changes the physical and biological properties dramatically.

Mechanism:
→ Galectin-3 Inhibition — the most distinctive mechanism of MCP; galectin-3 is a carbohydrate-binding protein expressed on cell surfaces; it plays roles in cellular adhesion, metastasis, fibrosis, and inflammation; MCP's galactose-rich fragments competitively bind to galectin-3 — blocking its activity; this mechanism is relevant not only for binding but for its anti-metastatic and anti-inflammatory effects.

→ Heavy Metal Chelation — MCP's polyuronide structure contains carboxylate groups (-COO⁻) that chelate heavy metal cations; particularly well-studied for lead, arsenic, and cadmium binding.

→ Gel Formation — in the gut, MCP forms a gel that physically traps molecules for elimination.

What it Binds:
→ Heavy Metals — particularly lead, arsenic, and cadmium; a clinical study demonstrated that MCP supplementation (PectaSol-C, 15g daily) produced significant increases in urinary lead, mercury, arsenic, and cadmium excretion in adults with detectable heavy metal burden — providing direct human
evidence of MCP's heavy metal chelation activity.

→ Through Galectin-3 Inhibition — not a conventional binding mechanism but relevant for:

→ Tumour Metastasis Prevention — galectin-3 mediates cancer cell adhesion; MCP inhibition of galectin-3 reduces metastatic potential in multiple cancer models.

→ Fibrosis Prevention — galectin-3 drives fibrosis in liver, heart, kidney, and lung; MCP inhibition of galectin-3 reduces fibrotic processes in multiple organ systems.

→ Inflammation — galectin-3 activates macrophages and drives inflammatory signalling; MCP reduces this.

→ LPS and Bacterial Components — some binding through gel formation.

What it Does NOT Bind:
→ Mycotoxins — lower affinity for mycotoxins compared to charcoal or CSM.

→ Organic solvents and non-polar compounds — limited affinity

Practical Considerations:
→ Molecular Weight Matters — only properly modified MCP (appropriate molecular weight reduction) has the galectin-3 inhibitory and heavy metal chelation activity; whole pectin or improperly modified pectin has different properties; look for clinical evidence of the specific product (PectaSol-C is the most researched brand).

→ Multiple Mechanisms — MCP is unusual among binders in having significant pharmacological activity (galectin-3 inhibition) beyond physical binding; this makes it one of the most multifunctional binders with potential applications in cancer prevention and fibrosis management alongside toxin binding.

→ Dissolves in Water — easy to use; mix in water or juice; can be taken with meals.

→ Dosing: 5–15g daily in divided doses; the heavy metal chelation studies used 15g daily; for general support 5g daily is a common maintenance dose; PectaSol-C is the most validated commercial preparation.

Silica (Silicon Dioxide) — the mycotoxin and inflammatory binder

What it is:
Silica in its amorphous (non-crystalline) form — as found in diatomaceous earth (the fossilised remains of diatoms — single-celled algae with silica cell walls), food-grade silica supplements, and orthosilicic acid — has specific binding and protective properties.

Mechanism:
→ Mechanical Abrasion — the diatomaceous earth form physically disrupts the exoskeletons of parasites and insect pests (its primary agricultural use) and may mechanically damage microbial biofilms

→ Physical Adsorption — the silica surface adsorbs mycotoxins, particularly aflatoxin and deoxynivalenol (DON — a trichothecene); several studies documenting silica-based adsorbents for mycotoxin binding in animal feed.

→ Silicon Supplementation — as covered in the bone health guide — silica from food and supplements supports connective tissue and bone health through silicon incorporation into collagen and hydroxyapatite.

What it Binds:
→ Mycotoxins — particularly deoxynivalenol (DON) and zearalenone; studies in livestock and some human data.

→ Some Heavy Metals — variable depending on form

→ Parasites — diatomaceous earth has mechanical effects on intestinal parasites

Practical Considerations:
→ Crystalline Versus Amorphous — crystalline silica (quartz dust) is highly toxic to the lungs; amorphous food-grade diatomaceous earth and food-grade silicon dioxide are the only forms appropriate for consumption; never use pool-grade or industrial diatomaceous earth.

→ Dosing: food-grade diatomaceous earth 1–2 teaspoons daily in water; food-grade silica supplement 20–50mg orthosilicic acid daily.

Fibre-based binders — the Foundational Dietary Approach

Dietary and supplemental fibres serve as binders through multiple mechanisms:

Psyllium Husk:
→ Soluble fibre forming a viscous gel in the intestinal lumen; the gel physically traps bile acids, cholesterol, and lipophilic compounds.

→ The most evidence-supported single fibre for binding bile acids and reducing their reabsorption; used pharmaceutically (Metamucil) and as a supplement.

→ Reduces LDL cholesterol through bile acid binding — the same mechanism that makes it relevant as a toxin binder.

→ Supports stool bulk and consistency — ensuring adequate transit time without constipation.

→ 5–10g daily in water; take separately from medications.

Calcium D-Glucarate:
→ As Covered in Multiple Guides — not a physical binder but a beta-glucuronidase inhibitor; prevents the bacterial deconjugation of glucuronide-conjugated toxins in the colon; preserves Phase 2 detoxification products for elimination rather than allowing their liberation and reabsorption

→ Indirect Binder Mechanism — by protecting the conjugated form of Phase 2 detox products, calcium D-glucarate ensures they pass through the intestine bound to glucuronide rather than being freed for reabsorption.
​
→ 500–1,000mg daily
Ground flaxseed:
→ Contains both soluble (mucilage) and insoluble fibre; the mucilage forms a gel that binds bile acids; the insoluble fibre adds bulk and promotes transit
→ Lignans in flaxseed are metabolised to enterolignans by gut bacteria; enterolignans reduce beta-glucuronidase activity (the same mechanism as calcium D-glucarate) — protecting conjugated oestrogens and other toxins from deconjugation
→ The combined binding and beta-glucuronidase-inhibiting actions make ground flaxseed one of the most comprehensively beneficial daily fibre sources for supporting toxin elimination
→ 1–2 tablespoons ground (not whole — whole passes undigested) daily
Oat beta-glucan:
→ The soluble fibre of oats; forms a viscous gel with high bile acid binding capacity; the primary mechanism of oats' cholesterol-lowering effect is bile acid binding with forced hepatic conversion of cholesterol to new bile acids
→ 3–6g beta-glucan daily (approximately 1–2 cups of cooked oats)
Acacia fibre (partially hydrolysed guar gum — PHGG):
→ As covered in the SIBO guide — PHGG supports gut motility, feeds beneficial bacteria, and improves stool consistency; indirect binder support through microbiome improvement reducing beta-glucuronidase activity
→ 5g daily in water
Specific mycotoxin binders — the mould illness protocol
For people with significant mould illness and mycotoxin exposure — specific binders have different efficacies for different mycotoxins:
→ Aflatoxin — bentonite clay, activated charcoal, CSM, chlorella, MCP; multiple options with varying evidence
→ Ochratoxin A — CSM is the most studied; activated charcoal; some bentonite; chlorella; emerging evidence for Saccharomyces cerevisiae cell wall preparations
→ Trichothecenes (including T-2 toxin, deoxynivalenol) — CSM, activated charcoal, silica, and emerging evidence for Saccharomyces cell wall beta-glucans; trichothecenes are among the most difficult mycotoxins to bind because of their relatively non-polar chemistry
→ Gliotoxin (from Aspergillus and Trichoderma) — Welchol (colesevelam) may be more effective than CSM for some Aspergillus-derived mycotoxins; activated charcoal; emerging evidence
→ Citrinin — limited binding data; activated charcoal and clay-based binders most commonly used
→ The Shoemaker Protocol — uses CSM (or Welchol for those who cannot tolerate CSM) as the primary mycotoxin binder in the CIRS/mould illness treatment sequence; this protocol situates binder use within a comprehensive mould exposure reduction, drainage support, and immune modulation framework
Saccharomyces cerevisiae cell wall beta-glucans — the emerging binder
→ The cell wall of brewer's yeast (Saccharomyces cerevisiae) contains beta-1,3/1,6-glucans — long-chain glucose polymers that have both immune-modulating and mycotoxin-binding properties
→ Specific affinity for ochratoxin A and some other mycotoxins through hydrogen bonding and physical entrapment in the beta-glucan matrix
→ Also immune-modulating through Dectin-1 receptor activation — adding an immune component to the binding function
→ Used in animal feed for mycotoxin management; emerging human clinical interest; 500–1,000mg daily of standardised beta-1,3/1,6-glucan preparation
𝐁𝐈𝐍𝐃𝐄𝐑 𝐒𝐄𝐋𝐄𝐂𝐓𝐈𝐎𝐍 — 𝐌𝐀𝐓𝐂𝐇𝐈𝐍𝐆 𝐁𝐈𝐍𝐃𝐄𝐑 𝐓𝐎 𝐓𝐎𝐗𝐈𝐍
The most important clinical decision in binder use — selecting the right binder for the specific toxin or condition:
Heavy metals (mercury, lead, cadmium, arsenic):
→ Primary: zeolite (clinoptilolite — particularly for lead, cadmium, caesium), modified citrus pectin (lead, arsenic, cadmium), chlorella (mercury, lead, cadmium)
→ Secondary: bentonite clay, IMD (intestinal metal detox — thiol-functionalised silica — a proprietary product with specific mercury affinity)
→ Combination often used: zeolite + chlorella + MCP for comprehensive heavy metal support
Mycotoxins:
→ Aflatoxin: bentonite clay, activated charcoal, CSM, chlorella
→ Ochratoxin A: CSM (Welchol), activated charcoal, Saccharomyces cell wall beta-glucans
→ Trichothecenes: CSM, activated charcoal, silica
→ Mixed/unknown mycotoxin exposure: CSM or Welchol (most commonly prescribed), or a combination of activated charcoal + bentonite clay
Oestrogen and hormone recirculation:
→ Primary: calcium D-glucarate (beta-glucuronidase inhibition), ground flaxseed (mucilage binding + lignan beta-glucuronidase inhibition), PSyllium husk (bile acid binding)
→ Secondary: DIM (reduces Phase 1 oestrogen metabolites at source — not a binder but reduces the load requiring binding), activated charcoal short-term
Bacterial endotoxins (LPS) and dysbiosis toxins:
→ Activated charcoal (broad spectrum)
→ Bentonite clay
→ Zeolite
→ Saccharomyces cell wall beta-glucans
→ Colestyramine and Welchol (in SIBO and significant dysbiosis contexts)
Environmental chemicals (pesticides, PCBs, dioxins):
→ Chlorella (specific evidence for dioxins)
→ Activated charcoal (broad organic compound binding)
→ Modified citrus pectin (some binding through gel formation)
→ Dietary fibre broadly — particularly pectin from apples and citrus
Bile acids and cholesterol:
→ PSyllium husk, oat beta-glucan, CSM, Welchol (pharmaceutical)
General support and maintenance:
→ Ground flaxseed + calcium D-glucarate — daily foundational support for everyone with significant toxic burden
→ Modified citrus pectin — daily maintenance for heavy metal support with additional galectin-3 benefits
→ Chlorella — ongoing maintenance for heavy metal and organic toxin binding
𝐖𝐇𝐀𝐓 𝐆𝐎𝐄𝐒 𝐖𝐑𝐎𝐍𝐆 𝐖𝐈𝐓𝐇 𝐁𝐈𝐍𝐃𝐄𝐑𝐒 — 𝐂𝐎𝐌𝐌𝐎𝐍 𝐌𝐈𝐒𝐓𝐀𝐊𝐄𝐒
Not opening drainage pathways first:
→ The most consequential mistake; using binders while the colon is constipated is counterproductive — the bound toxins have nowhere to go and may be released when the binder eventually reaches a stagnant, bacteria-filled colon environment; always establish daily bowel movement before commencing binder use
→ As covered in the drainage pathways guide — the sequence is: open colon → support liver and bile → support lymphatics → then use binders to capture what the open drainage pathways are now able to eliminate
Not separating from medications and nutrients:
→ Activated charcoal and CSM are the most problematic; they bind many medications and nutrients with the same efficiency as toxins; taking them within 2 hours of medications or supplements can dramatically reduce absorption of those inputs
→ Even more selective binders (zeolite, MCP) should be separated by 30–60 minutes from nutrients and medications to avoid any binding interference
→ The generally recommended separation: take binders away from meals and all supplements; 1–2 hours before or 2 hours after; with only water
Producing constipation:
→ All binders add bulk to intestinal contents and most have some degree of water-absorbing or stool-solidifying effect; without adequate hydration and motility support they can produce or worsen constipation — the opposite of what is needed for drainage
→ Always accompany binder use with: adequate hydration (extra 500ml–1L daily), magnesium glycinate at night, and dietary fibre support
Herxheimer and mobilisation reactions — not understanding the cause:
→ When binders are used alongside treatments that mobilise toxins (antimicrobials killing bacteria and releasing LPS, chelation mobilising heavy metals, antifungals killing Candida and releasing ergosterol and mycotoxins) — the binders reduce but do not eliminate herxheimer reactions
→ Starting too high a dose of binders too quickly in a heavily burdened person can itself trigger mobilisation reactions as binders create a concentration gradient pulling more toxins into the gut lumen from systemic compartments
→ Start low — particularly chlorella and zeolite — and increase the dose gradually over 2–4 weeks
Using binders continuously without monitoring nutrient status:
→ Long-term use of broad-spectrum binders (activated charcoal, CSM) — without monitoring fat-soluble vitamin status and without taking vitamins separated from the binder — will produce fat-soluble vitamin deficiencies
→ Check vitamin D, vitamin K2 status, and fat-soluble vitamin intake when using broad binders long-term; supplement fat-soluble vitamins at times strictly separated from binder doses
Not matching binder to toxin:
→ Using activated charcoal for heavy metal detoxification — which charcoal does not bind well — while not using zeolite or MCP which do; or using clay for mycotoxins without CSM or Welchol which have much higher affinity for the specific mycotoxins involved in CIRS
→ Clinical effectiveness requires matching the binder to the specific toxin being addressed
Poor quality products:
→ Bentonite clay and zeolite from unreliable sources may themselves contain heavy metal contamination; chlorella must be tested for heavy metals in its growing medium; activated charcoal products vary significantly in surface area and pore structure; only use products from reputable suppliers with third-party contamination testing
𝐇𝐎𝐖 𝐓𝐎 𝐔𝐒𝐄 𝐁𝐈𝐍𝐃𝐄𝐑𝐒 — 𝐓𝐇𝐄 𝐏𝐑𝐀𝐂𝐓𝐈𝐂𝐀𝐋 𝐏𝐑𝐎𝐓𝐎𝐂𝐎𝐋
Timing principles:
→ On an empty stomach where possible — away from food, medications, and supplements
→ Minimum separation from other inputs:
→ Activated charcoal: 2 hours before or 2 hours after all medications and supplements; the strictest separation requirement
→ CSM/Welchol: 1–2 hours before or 4–6 hours after all medications; 2 hours from supplements
→ Bentonite clay: 1–2 hours from other inputs
→ Zeolite, MCP, chlorella: 30–60 minutes from other inputs is generally considered adequate; these more selective binders have lower interference risk
→ With water — always with a full glass of water; hydration is essential for binder safety and efficacy
Sequencing within the day — a practical example:
→ 7am: Wake; take zeolite + chlorella (heavy metal binders) with water on empty stomach
→ 7:30am: Exercise
→ 8:30am: Breakfast with all food-based nutrients and fat-soluble vitamins
→ 9am: Take methylated B vitamins, fish oil, and other supplements with or after breakfast
→ 11am: Take MCP in water between meals
→ 1pm: Lunch; take calcium D-glucarate
→ 3pm: Take activated charcoal (if using) between meals
→ 6pm: Dinner; take milk thistle, artichoke — liver support with meal
→ 9pm: Take magnesium glycinate for bowel motility and sleep
→ 10pm: Bedtime; consider PSyllium husk in water before bed (increases stool bulk for morning elimination)
The binder rotation concept:
→ Some integrative practitioners rotate binders — using different binders on different days or in different weeks — to provide:
→ Coverage of a broader spectrum of toxins than any single binder provides
→ Reduction in the risk of any single binder's nutrient-binding or other side effects accumulating
→ Avoidance of adaptation — theoretical concern that the gut may adapt to the continued presence of a single binding substance
→ Practical rotation example: activated charcoal Monday/Thursday; bentonite clay Tuesday/Friday; zeolite + chlorella daily; MCP daily
Duration of binder use:
→ Depends entirely on the clinical context and the toxin load being addressed
→ Acute applications (food poisoning, drug overdose): single high-dose use
→ CIRS/mould illness protocol: CSM or Welchol typically used for months as part of the full Shoemaker Protocol; until VCS (visual contrast sensitivity) and biomarker normalisation
→ Heavy metal detoxification: zeolite, chlorella, and MCP may be used for 3–6 months or longer during active chelation protocols
→ General ongoing maintenance: lower doses of chlorella, MCP, and ground flaxseed can be used indefinitely as part of a daily toxin management approach; activated charcoal and CSM are generally short-term or intermittent rather than indefinite
𝐓𝐇𝐄 𝐁𝐈𝐍𝐃𝐄𝐑 𝐓𝐎𝐎𝐋𝐊𝐈𝐓 — 𝐒𝐔𝐌𝐌𝐀𝐑𝐘 𝐁𝐘 𝐀𝐏𝐏𝐋𝐈𝐂𝐀𝐓𝐈𝐎𝐍
For heavy metals:
→ Clinoptilolite zeolite — 1–3g daily
→ Modified citrus pectin (PectaSol-C) — 5–15g daily
→ Chlorella pyrenoidosa (intact cell wall) — 3–6g daily
→ IMD (intestinal metal detox) — thiol-silica for mercury specifically
For mycotoxins/mould illness:
→ Cholestyramine (prescription) — 4g 2–4x daily per Shoemaker Protocol
→ Welchol/colesevelam (prescription) — alternative to CSM
→ Activated charcoal — 500mg–2g 2–3x daily
→ Saccharomyces cell wall beta-glucans — 500–1,000mg daily
For oestrogen and hormone recirculation:
→ Calcium D-glucarate — 500–1,000mg daily
→ Ground flaxseed — 2 tablespoons daily
→ PSyllium husk — 5–10g daily
For general daily support and maintenance:
→ Ground flaxseed — 2 tablespoons daily (fibre, binding, beta-glucuronidase inhibition)
→ Calcium D-glucarate — 500mg daily
→ Modified citrus pectin — 5g daily
→ Chlorella (broken cell wall for nutrition; intact cell wall for binding)
𝐄𝐗𝐏𝐋𝐎𝐑𝐄 𝐌𝐎𝐑𝐄 𝐅𝐑𝐄𝐄 𝐇𝐄𝐀𝐋𝐈𝐍𝐆 𝐓𝐎𝐎𝐋𝐒:
→ Tap Pete Wurst
→ Scroll to the top pinned post
That’s where the Healing Hub Library is.
𝐓𝐇𝐄 𝐃𝐄𝐄𝐏𝐄𝐑 𝐓𝐑𝐔𝐓𝐇
The concept of a binder is elegant in its simplicity and consequential in its clinical application.
The liver works. It conjugates. It packages toxins into bile. It does its extraordinary detoxification work — night and day, continuously — processing every lipophilic compound that enters from the gut, every catecholamine metabolite from stress, every xenoestrogen absorbed from the food supply and the environment.
And then it excretes the packages into the bile duct.
And without a binder — a significant proportion of those packages arrive in the small intestine and are unwrapped. The beta-glucuronidase enzyme of dysbiotic gut bacteria hydrolyses the glucuronide conjugate. The bile acid carrier that was escorting the toxin to elimination reverses course at the terminal ileum. The lipophilic compound diffuses back across the intestinal membrane. And the whole process starts again.
The liver reprocesses. Phase 1 enzymes run again. Phase 2 enzyme capacity is consumed again. Reactive intermediates from Phase 1 generate oxidative stress again. The glutathione supply is depleted again. And the same toxin — processed, packaged, and shipped once — returns for a second, third, fourth, fifth journey through the hepatic detoxification machinery.
This is not a theoretical inefficiency. It is a clinically measurable phenomenon that explains why detoxification protocols that do not include binders so frequently produce suboptimal outcomes and recirculation reactions — why the heavy metals measured in provocation challenge tests keep appearing cycle after cycle; why the mycotoxin burden in mould illness patients does not decline with environmental remediation and drainage support alone; why oestrogen dominance is so resistant to liver support measures when beta-glucuronidase in the colon is liberating oestrogen conjugates faster than the liver can reprocess them.
The right binder, matched to the right toxin, used at the right time, with drainage pathways open, with adequate hydration, separated appropriately from nutrients and medications — is one of the most elegant interventions in the functional medicine toolkit.
Not because it does something dramatic.
But because it completes the process that the body has already been doing — the liver processing, the bile carrying, the gut eliminating — and ensures that what the body intends to eliminate actually leaves.
The work was already being done.
The binder is just making sure it counts.
© 2026 Pete Wurst — All Rights Reserved. This content is for educational purposes only and is not intended as medical advice.